Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation
Open accessThe DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Abstract
The prevalence of metabolic-related disorders, such as non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (DM2), has been increasing. Therefore, developing improved methods for the prevention, treatment, and detection of these two conditions is also necessary. In this study, our primary focus was on examining the role of chronic inflammation as a potential link in the pathogenesis of these diseases and their interconnections. A comprehensive search of the PubMed database using keywords such as “non-alcoholic fatty liver disease”, “type 2 diabetes mellitus”, “chronic inflammation”, “pathogenesis”, and “progression” yielded 177 relevant papers for our analysis. The findings of our study revealed intricate relationships between the pathogenesis of NAFLD and DM2, emphasizing the crucial role of inflammatory processes. These connections involve various molecular functions, including altered signaling pathways, patterns of gene methylation, the expression of related peptides, and up- and downregulation of several genes. Our study is a foundational platform for future research into the intricate relationship between NAFLD and DM2, allowing for a better understanding of the underlying mechanisms and the potential for introducing new treatment standards.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., Stein, C., Basit, A., Chan, J. C. N., Mbanya, J. C., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109119 · Cited by 10,123
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
Estes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
Riazi, K., Azhari, H., Charette, J. H., Underwood, F. E., King, J. A., Afshar, E. E., Swain, M. G., Congly, S. E., Kaplan, G. G., & Shaheen, A.-A. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00165-0 · Cited by 2,246
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020786 · Cited by 1,441
Diabetes mellitus: The epidemic of the century
Kharroubi, A. T. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.850 · Cited by 1,229
Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164
Tilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002
Magkos, F., Fraterrigo, G., Yoshino, J., Luecking, C., Kirbach, K., Kelly, S. C., de las Fuentes, L., He, S., Okunade, A. L., Patterson, B. W., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.02.005 · Cited by 886
Stefan, N., Häring, H.-U., & Cusi, K. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30154-2 · Cited by 837
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Smith, G. I., Shankaran, M., Yoshino, M., Schweitzer, G. G., Chondronikola, M., Beals, J. W., Okunade, A. L., Patterson, B. W., Nyangau, E., Field, T., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134165 · Cited by 771
Mauer, J., Chaurasia, B., Goldau, J., Vogt, M. C., Ruud, J., Nguyen, K. D., Theurich, S., Hausen, A. C., Schmitz, J., Brönneke, H. S., et al. (2014) · Nature Immunology · doi:10.1038/ni.2865 · Cited by 727
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
Le, M. H., Yeo, Y. H., Li, X., Li, J., Zou, B., Wu, Y., Ye, Q., Huang, D. Q., Zhao, C., Zhang, J., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.002 · Cited by 711
Tanase, D. M., Gosav, E. M., Costea, C. F., Ciocoiu, M., Lacatusu, C. M., Maranduca, M. A., Ouatu, A., & Floria, M. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3920196 · Cited by 627 · cited 1×
“Hyperinsulinemia related to DM2, which occurs to overcome IR, results in alterations in the hepatic clearance of insulin and promotes NAFLD development [47].”
BackgroundFibroblasts as immune regulators in infection, inflammation and cancer
Davidson, S., Coles, M., Thomas, T., Kollias, G., Ludewig, B., Turley, S., Brenner, M., & Buckley, C. D. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00540-z · Cited by 605
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
Zhang, C.-Y., Yuan, W.-G., He, P., Lei, J.-H., & Wang, C.-X. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i48.10512 · Cited by 594
Macrophage Polarization and Its Role in Liver Disease
Wang, C., Ma, C., Gong, L., Guo, Y., Fu, K., Zhang, Y., Zhou, H., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803037 · Cited by 581
Wan, J., Benkdane, M., Teixeira-Clerc, F., Bonnafous, S., Louvet, A., Lafdil, F., Pecker, F., Tran, A., Gual, P., Mallat, A., et al. (2014) · Hepatology · doi:10.1002/hep.26607 · Cited by 558
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
Miura, K., Yang, L., van Rooijen, N., Ohnishi, H., & Seki, E. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00365.2011 · Cited by 503 · cited 1×
“Researchers have revealed an association between C–C chemokine receptor type 2 (CCR2) and type 5 (CCR5) and their ligands (CCL2 and CCL5) concerning liver fibrosis [96,97].”
BackgroundAn Update on the Epidemiology of Type 2 Diabetes
Tinajero, M. G., & Malik, V. S. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.013 · Cited by 471
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
Armstrong, M. J., Hull, D., Guo, K., Barton, D., Hazlehurst, J. M., Gathercole, L. L., Nasiri, M., Yu, J., Gough, S. C., Newsome, P. N., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.038 · Cited by 456
NAFLD as a driver of chronic kidney disease
Byrne, C. D., & Targher, G. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.013 · Cited by 449
MAFLD: How is it different from NAFLD?
Gofton, C., Upendran, Y., Zheng, M.-H., & George, J. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0367 · Cited by 423
Parolini, M. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.140043 · Cited by 420
Ligthart, S., Vaez, A., Võsa, U., Stathopoulou, M. G., de Vries, P. S., Prins, B. P., Van der Most, P. J., Tanaka, T., Naderi, E., Rose, L. M., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.09.009 · Cited by 419
Chronic Complications of Diabetes Mellitus: A Mini Review
Lotfy, M., Adeghate, J., Kalasz, H., Singh, J., & Adeghate, E. (2016) · Current Diabetes Reviews · doi:10.2174/1573399812666151016101622 · Cited by 414
Hasegawa, T., Yoneda, M., Nakamura, K., Makino, I., & Terano, A. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01083.x · Cited by 408
NAFLD: Mechanisms, Treatments, and Biomarkers
Nassir, F. (2022) · Biomolecules · doi:10.3390/biom12060824 · Cited by 405
Mantovani, A., Petracca, G., Beatrice, G., Csermely, A., Lonardo, A., Schattenberg, J. M., Tilg, H., Byrne, C. D., & Targher, G. (2022) · Gut · doi:10.1136/gutjnl-2020-323082 · Cited by 402
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
Yamamura, S., Eslam, M., Kawaguchi, T., Tsutsumi, T., Nakano, D., Yoshinaga, S., Takahashi, H., Anzai, K., George, J., & Torimura, T. (2020) · Liver International · doi:10.1111/liv.14675 · Cited by 401 · cited 1×
“Clinicians can establish the diagnosis of MAFLD when liver steatosis coexists with at least one of the following criteria: overweight, diagnosis of DM2, or the presence of at least two out of five metabolic syndrome risk factors [22,23].”
BackgroundInfluentialRatziu, V., Sanyal, A., Harrison, S. A., Wong, V. W., Francque, S., Goodman, Z., Aithal, G. P., Kowdley, K. V., Seyedkazemi, S., Fischer, L., et al. (2020) · Hepatology · doi:10.1002/hep.31108 · Cited by 378
Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus
Rehman, K., Akash, M. S. H., Liaqat, A., Kamal, S., Qadir, M. I., & Rasul, A. (2017) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2017019712 · Cited by 377
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
Gorden, D. L., Myers, D. S., Ivanova, P. T., Fahy, E., Maurya, M. R., Gupta, S., Min, J., Spann, N. J., McDonald, J. G., Kelly, S. L., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p056002 · Cited by 372 · cited 2×
“The activation of these genes triggers a cascade of events involving inflammatory processes, lipid metabolism regulation, and remodeling of the extracellular matrix [90].”
BackgroundAssociation of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
Duan, Y., Pan, X., Luo, J., Xiao, X., Li, J., Bestman, P. L., & Luo, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880298 · Cited by 358
Püschel, G. P., Klauder, J., & Henkel, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154358 · Cited by 344
Kelly, B., Tannahill, G. M., Murphy, M. P., & O'Neill, L. A. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662114 · Cited by 334
FGF21 as Modulator of Metabolism in Health and Disease
Tezze, C., Romanello, V., & Sandri, M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00419 · Cited by 315
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
Cavelti-Weder, C., Babians-Brunner, A., Keller, C., Stahel, M. A., Kurz-Levin, M., Zayed, H., Solinger, A. M., Mandrup-Poulsen, T., Dinarello, C. A., & Donath, M. Y. (2012) · Diabetes Care · doi:10.2337/dc11-2219 · Cited by 294
Dominguez, H., Storgaard, H., Rask-Madsen, C., Steffen Hermann, T., Ihlemann, N., Baunbjerg Nielsen, D., Spohr, C., Kober, L., Vaag, A., & Torp-Pedersen, C. (2005) · Journal of Vascular Research · doi:10.1159/000088261 · Cited by 286
Evolution of NAFLD and Its Management
Mundi, M. S., Velapati, S., Patel, J., Kellogg, T. A., Abu Dayyeh, B. K., & Hurt, R. T. (2020) · Nutrition in Clinical Practice · doi:10.1002/ncp.10449 · Cited by 285
Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications
Pollack, R. M., Donath, M. Y., LeRoith, D., & Leibowitz, G. (2016) · Diabetes Care · doi:10.2337/dcs15-3015 · Cited by 262
Yang, B. T., Dayeh, T. A., Kirkpatrick, C. L., Taneera, J., Kumar, R., Groop, L., Wollheim, C. B., Nitert, M. D., & Ling, C. (2011) · Diabetologia · doi:10.1007/s00125-010-1967-6 · Cited by 251
Tuomainen, M., Lindström, J., Lehtonen, M., Auriola, S., Pihlajamäki, J., Peltonen, M., Tuomilehto, J., Uusitupa, M., de Mello, V. D., & Hanhineva, K. (2018) · Nutrition & Diabetes · doi:10.1038/s41387-018-0046-9 · Cited by 242
Videla, L. A., Rodrigo, R., Araya, J., & Poniachik, J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.033 · Cited by 239
Xue, L., Deng, Z., Luo, W., He, X., & Chen, Y. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.759306 · Cited by 238
Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo
Williams, K. H., Shackel, N. A., Gorrell, M. D., McLennan, S. V., & Twigg, S. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1009 · Cited by 233
The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk
Caussy, C., Aubin, A., & Loomba, R. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01383-7 · Cited by 230
Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
Khomich, O., Ivanov, A. V., & Bartosch, B. (2019) · Cells · doi:10.3390/cells9010024 · Cited by 224
Albano, E., Mottaran, E., Vidali, M., Reale, E., Saksena, S., Occhino, G., Burt, A. D., & Day, C. P. (2005) · Gut · doi:10.1136/gut.2004.057968 · Cited by 219
Genetic predisposition in nonalcoholic fatty liver disease
Sookoian, S., & Pirola, C. J. (2017) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2016.0109 · Cited by 213
Hernández-Alvarez, M. I., Thabit, H., Burns, N., Shah, S., Brema, I., Hatunic, M., Finucane, F., Liesa, M., Chiellini, C., Naon, D., et al. (2010) · Diabetes Care · doi:10.2337/dc09-1305 · Cited by 189
de Oliveira, S., Houseright, R. A., Graves, A. L., Golenberg, N., Korte, B. G., Miskolci, V., & Huttenlocher, A. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.11.034 · Cited by 189
The Role of Chemokines in Acute Liver Injury
Saiman, Y., & Friedman, S. L. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00213 · Cited by 180
Mohamad Nor, M. H., Ayob, N., Mokhtar, N. M., Raja Ali, R. A., Tan, G. C., Wong, Z., Shafiee, N. H., Wong, Y. P., Mustangin, M., & Nawawi, K. N. M. (2021) · Nutrients · doi:10.3390/nu13093192 · Cited by 173
Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
Valenti, L., Bugianesi, E., Pajvani, U., & Targher, G. (2016) · Liver International · doi:10.1111/liv.13185 · Cited by 171
Mensink, M., Hesselink, M. K. C., Russell, A. P., Schaart, G., Sels, J.-P., & Schrauwen, P. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803567 · Cited by 160
Wu, L., Mo, W., Feng, J., Li, J., Yu, Q., Li, S., Zhang, J., Chen, K., Ji, J., Dai, W., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15099 · Cited by 160
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms
Saponaro, C., Gaggini, M., & Gastaldelli, A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0607-4 · Cited by 156
Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD
Takahashi, H., Kessoku, T., Kawanaka, M., Nonaka, M., Hyogo, H., Fujii, H., Nakajima, T., Imajo, K., Tanaka, K., Kubotsu, Y., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1696 · Cited by 153
SYSTEMIC INFLAMMATION INCREASES INTESTINAL PERMEABILITY DURING EXPERIMENTAL HUMAN ENDOTOXEMIA
Hietbrink, F., Besselink, M. G. H., Renooij, W., de Smet, M. B. M., Draisma, A., van der Hoeven, H., & Pickkers, P. (2009) · Shock · doi:10.1097/shk.0b013e3181a2bcd6 · Cited by 151
Lê, K.-A., Mahurkar, S., Alderete, T. L., Hasson, R. E., Adam, T. C., Kim, J. S., Beale, E., Xie, C., Greenberg, A. S., Allayee, H., et al. (2011) · Diabetes · doi:10.2337/db10-1263 · Cited by 150
Echinatin effectively protects against NLRP3 inflammasome–driven diseases by targeting HSP90
Xu, G., Fu, S., Zhan, X., Wang, Z., Zhang, P., Shi, W., Qin, N., Chen, Y., Wang, C., Niu, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.134601 · Cited by 148
Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ
Feng, X., Qin, H., Shi, Q., Zhang, Y., Zhou, F., Wu, H., Ding, S., Niu, Z., Lü, Y., & Shen, P. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.03.016 · Cited by 146
The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus
Ahmed, S. A. H., Ansari, S. A., Mensah‐Brown, E. P. K., & Emerald, B. S. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00896-4 · Cited by 146
Rissanen, A., Howard, C. P., Botha, J., Thuren, T., & for the Global Investigators (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01637.x · Cited by 140
Bruzzì, S., Sutti, S., Giudici, G., Burlone, M. E., Ramavath, N. N., Toscani, A., Bozzola, C., Schneider, P., Morello, E., Parola, M., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.015 · Cited by 139
Interleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control
Lang Lehrskov, L., Lyngbaek, M. P., Soederlund, L., Legaard, G. E., Ehses, J. A., Heywood, S. E., Wewer Albrechtsen, N. J., Holst, J. J., Karstoft, K., Pedersen, B. K., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.008 · Cited by 135
Ruscitti, P., Masedu, F., Alvaro, S., Airò, P., Battafarano, N., Cantarini, L., Cantatore, F. P., Carlino, G., D'Abrosca, V., Frassi, M., et al. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002901 · Cited by 135
The intersection of metformin and inflammation
Bharath, L. P., & Nikolajczyk, B. S. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00604.2020 · Cited by 134
Decreased Adipose Tissue Oxygenation Associates with Insulin Resistance in Individuals with Obesity
Cifarelli, V., Beeman, S. C., Smith, G. I., Yoshino, J., Morozov, D., Beals, J. W., Kayser, B. D., Watrous, J. D., Jain, M., Patterson, B. W., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141828 · Cited by 132 · cited 4×
“[103] confirmed the relationship between low levels of oxygenation”
BackgroundInfluentialPPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men
Lucia, A., Gómez-Gallego, F., Barroso, I., Rabadán, M., Bandrés, F., San Juan, A. F., Chicharro, J. L., Ekelund, U., Brage, S., Earnest, C. P., et al. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00037.2005 · Cited by 131
Cheng, R., Wang, L., Le, S., Yang, Y., Zhao, C., Zhang, X., Yang, X., Xu, T., Xu, L., Wiklund, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29968-0 · Cited by 128
Oliveira, C. P. M. S., Da Costa Gayotto, L. C., Tatai, C., Della Bina, B. I., Janiszewski, M., Lima, E. S., Abdalla, D. S. P., Lopasso, F. P., Laurindo, F. R. M., & Laudanna, A. A. (2002) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2002.tb00518.x · Cited by 127
Wang, Y., Parlevliet, E. T., Geerling, J. J., van der Tuin, S. J. L., Zhang, H., Bieghs, V, Jawad, A. H. M., Shiri‐Sverdlov, R., Bot, I., de Jager, S. C. A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12490 · Cited by 126
The Emerging Role of B Cells in the Pathogenesis of NAFLD
Barrow, F., Khan, S., Wang, H., & Revelo, X. S. (2021) · Hepatology · doi:10.1002/hep.31889 · Cited by 126 · cited 2×
“Accumulating evidence suggests the involvement of hepatic B lymphocytes in the development of NAFLD and its progression to NASH [87].”
BackgroundKim, S. H., Kim, K. H., Kim, H.-K., Kim, M.-J., Back, S. H., Konishi, M., Itoh, N., & Lee, M.-S. (2015) · Diabetologia · doi:10.1007/s00125-014-3475-6 · Cited by 124 · cited 3×
“In another study, it was revealed that NAFLD is related to the serum level of fibroblast growth factor 21 (FGF21) [82].”
BackgroundAnti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin
Grotta, R. L., de Candia, P., Olivieri, F., Matacchione, G., Giuliani, A., Rippo, M. R., Tagliabue, E., Mancino, M., Rispoli, F., Ferroni, S., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04289-z · Cited by 124
Chen, Y., Feng, R., Yang, X., Dai, J., Huang, M., Ji, X., Li, Y., Okekunle, A. P., Gao, G., Onwuka, J. U., et al. (2019) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy358 · Cited by 122
Loomba, R., Morgan, E., Watts, L., Xia, S., Hannan, L. A., Geary, R. S., Baker, B. F., & Bhanot, S. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30186-2 · Cited by 116
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship
Muzica, C. M., Sfarti, C. V., Trifan, A. V., Zenovia, S., Cuciureanu, T., Năstasă, R., Huiban, L., Cojocariu, C., Sîngeap, A.-M., Gîrleanu, I., et al. (2020) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2020/6638306 · Cited by 114
Lin, Y., Chang, P., Chang, M., & Ni, Y. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.079749 · Cited by 113
Aspirin use is associated with lower indices of liver fibrosis among adults in the United States
Jiang, Z. G., Feldbrügge, L., Tapper, E. B., Popov, Y., Ghaziani, T., Afdhal, N., Robson, S. C., & Mukamal, K. J. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13515 · Cited by 107
Inflammation as A Precursor of Atherothrombosis, Diabetes and Early Vascular Aging
Barbu, E., Popescu, M.-R., Popescu, A.-C., & Balanescu, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020963 · Cited by 107
Cusi, K., Kashyap, S., Gastaldelli, A., Bajaj, M., & Cersosimo, E. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00624.2006 · Cited by 105
GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study
Ellingsgaard, H., Seelig, E., Timper, K., Coslovsky, M., Soederlund, L., Lyngbæk, M. P. P., Albrechtsen, N. J. W., Schmidt‐Trucksäss, A., Hanssen, H., Frey, W. O., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-05045-y · Cited by 105
Obesity depresses the anti‐inflammatory HSP 70 pathway, contributing to NAFLD progression
Cangeri Di Naso, F., Rosa Porto, R., Sarubbi Fillmann, H., Maggioni, L., Vontobel Padoin, A., Jacques Ramos, R., Corá Mottin, C., Bittencourt, A., Anair Possa Marroni, N., & Ivo Homem de Bittencourt, P. (2015) · Obesity · doi:10.1002/oby.20919 · Cited by 105
Lei, Y., Tang, L., Chen, Q., Wu, L., He, W., Tu, D., Wang, S., Chen, Y., Liu, S., Xie, Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34671-1 · Cited by 104
Progress in Nonalcoholic Fatty Liver Disease: SIRT Family Regulates Mitochondrial Biogenesis
Zeng, C., & Chen, M. (2022) · Biomolecules · doi:10.3390/biom12081079 · Cited by 102
Yoneda, M., Honda, Y., Ogawa, Y., Kessoku, T., Kobayashi, T., Imajo, K., Ozaki, A., Nogami, A., Taguri, M., Yamanaka, T., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001990 · Cited by 99
Pancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction
Ehses, J. A., Ellingsgaard, H., Böni-Schnetzler, M., & Donath, M. Y. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903025879 · Cited by 97 · cited 6×
“The role of the inflammatory process in the pathogenesis of DM2 and NAFLD was highlighted in previous sections; nevertheless, the interplay between inflammation, DM2, and NAFLD should be discussed in more detail.”
BackgroundInfluentialMosca, A., Crudele, A., Smeriglio, A., Braghini, M. R., Panera, N., Comparcola, D., Alterio, A., Sartorelli, M. R., Tozzi, G., Raponi, M., et al. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.09.021 · Cited by 88
Nadinskaia, M. Y., Maevskaya, M. V., Ivashkin, V. T., Kodzoeva, K. B., Пирогова, И. Ю., Ev, C., Nersesov, A., Kaibullayeva, J. A., Konysbekova, A., Raissova, A., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i10.959 · Cited by 88
Ellulu, M. S., & Samouda, H. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00925-0 · Cited by 86
Hunter, D. J., James, L. S., Hussey, B., Wadley, A. J., Lindley, M. R., & Mastana, S. S. (2019) · Epigenetics · doi:10.1080/15592294.2019.1582276 · Cited by 85
Chong, P. L., Laight, D. W., Aspinall, R., Higginson, A., & Cummings, M. H. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01660-5 · Cited by 84
Fisk, H. L., Childs, C. E., Miles, E. A., Ayres, R., Noakes, P. S., Paras-Chavez, C., Kuda, O., Kopecký, J., Antoun, E., Lillycrop, K. A., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103909 · Cited by 82
Farrokhian, A., Raygan, F., Soltani, A., Ebrahimi, M. T., Sharifi, M., Karami, A. A., & Asemi, Z. (2017) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-017-9343-1 · Cited by 82
Herrera, M. F., Pantoja, J. P., Velázquez-Fernández, D., Cabiedes, J., Aguilar-Salinas, C., García-García, E., Rivas, A., Villeda, C., Hernández-Ramírez, D. F., Dávila, A., et al. (2010) · Diabetes Care · doi:10.2337/dc09-1833 · Cited by 80
Krysiak, R. G., Gdula‐Dymek, A., & Okopień, B. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.11.023 · Cited by 77
Lima, M. M. O., Pareja, J. C., Alegre, S. M., Geloneze, S. R., Kahn, S. E., Astiarraga, B. D., Chaim, É. A., Baracat, J., & Geloneze, B. (2013) · Obesity · doi:10.1002/oby.20030 · Cited by 75
Rabbani, N., Xue, M., Weickert, M. O., & Thornalley, P. J. (2021) · Nutrients · doi:10.3390/nu13072374 · Cited by 74
Vilar-Gomez, E., Pirola, C. J., Sookoian, S., Wilson, L. A., Belt, P., Liang, T., Liu, W., & Chalasani, N. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001072 · Cited by 68
Chang, C., Wu, C., Su, W., Shih, K., Tarng, D., Chou, C., Chen, T.-Y., Kor, C., & Wu, H.-M. (2015) · Scientific Reports · doi:10.1038/srep10096 · Cited by 66
Shen, H., Shahzad, G., Jawairia, M., Bostick, R. M., & Mustacchia, P. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12944 · Cited by 64
Nakao, Y., Amrollahi, P., Parthasarathy, G., Mauer, A. S., Sehrawat, T. S., Vanderboom, P. M., Nair, K. S., Nakao, K., Allen, A. M., Hu, Y., et al. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102430 · Cited by 63
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis
Frenette, C., Kayali, Z., Mena, E., Mantry, P. S., Lucas, K. J., Neff, G., Rodriguez, M., Thuluvath, P. J., Weinberg, E., Bhandari, B. R., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.09.029 · Cited by 62
The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
Kosmalski, M., Ziółkowska, S., Czarny, P. L., Szemraj, J., & Pietras, T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051375 · Cited by 62
Self-citationSharma, A., Anand, S. K., Singh, N., Dwarkanath, A., Dwivedi, U. N., & Kakkar, P. (2021) · Food & Function · doi:10.1039/d0fo02501a · Cited by 61
Weber, K. S., Nowotny, B., Straßburger, K., Pacini, G., Müssig, K., Szendroedi, J., Herder, C., Roden, M., & for the GDS Group (2015) · Diabetes Care · doi:10.2337/dc15-0169 · Cited by 60
Sleep-disordered breathing, circulating exosomes, and insulin sensitivity in adipocytes
Khalyfa, A., Gozal, D., Masa, J. F., Marin, J. M., Qiao, Z., Corral, J., González, M., Marti, S., Kheirandish-Gozal, L., Egea, C., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0099-9 · Cited by 59
Lin, Y., Chang, P., Chang, M., & Ni, Y. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.046417 · Cited by 59
van Poppel, P. C. M., van Asseldonk, E. J. P., Holst, J. J., Vilsbøll, T., Netea, M. G., & Tack, C. J. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12357 · Cited by 58
Calabrese, F., Disciglio, V., Franco, I., Sorino, P., Bonfiglio, C., Bianco, A., Campanella, A., Lippolis, T., Pesole, P., Polignano, M., et al. (2022) · Nutrients · doi:10.3390/nu14091773 · Cited by 58
Role of Kupffer Cells in Driving Hepatic Inflammation and Fibrosis in HIV Infection
Zhang, L., & Bansal, M. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01086 · Cited by 57
Animal experiment and clinical study of effect of gamma-interferon on hepatic fibrosis
Weng, H. L. (2001) · World Journal of Gastroenterology · doi:10.3748/wjg.v7.i1.42 · Cited by 56
OxNASH Score Correlates with Histologic Features and Severity of Nonalcoholic Fatty Liver Disease
Alkhouri, N., Berk, M. P., Yerian, L. M., López, R., Chung, Y. M., Zhang, R., McIntyre, T. M., Feldstein, A. E., & Hazen, S. L. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3031-8 · Cited by 52
Abderrazak, A., Hadri, K. E., Bosc, E., Blondeau, B., Slimane, M.-N., Büchele, B., Simmet, T., Couchie, D., & Rouis, M. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232934 · Cited by 51
Kato, T., Honda, Y., Kurita, Y., Iwasaki, A., Sato, T., Kessoku, T., Uchiyama, S., Ogawa, Y., Ohkubo, H., Higurashi, T., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175626 · Cited by 50
Interleukin-6 mediates exercise-induced increase in insulin sensitivity in mice
Benrick, A., Wallenius, V., & Asterholm, I. W. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.065508 · Cited by 49
Cytokines Genotype‐Phenotype Correlation in Nonalcoholic Steatohepatitis
Bocșan, I. C., Milaciu, M. V., Pop, R. M., Vesa, Ș. C., Ciumărnean, L., Matei, D. M., & Buzoianu, A. D. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4297206 · Cited by 49
Peters, K. M., Wilson, R. B., & Borradaile, N. M. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000535 · Cited by 48
Genovese, M. C., Burmester, G. R., HAGINO, O. R., Thangavelu, K., Iglesias‐Rodriguez, M., John, G. S., González-Gay, M. Á., Mandrup-Poulsen, T. R., & Fleischmann, R. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02229-5 · Cited by 46
Anti‐inflammatory effects of linagliptin in hemodialysis patients with diabetes
Nakamura, Y., Tsuji, M., Hasegawa, H., Kimura, K., Fujita, K., Inoue, M., Shimizu, T., Gotoh, H., Goto, Y., Inagaki, M., et al. (2014) · Hemodialysis International · doi:10.1111/hdi.12127 · Cited by 46
Musazadeh, V., Dehghan, P., Saleh‐Ghadimi, S., & Farhangi, M. A. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14744 · Cited by 45
Yoneda, M., Kobayashi, T., Honda, Y., Ogawa, Y., Kessoku, T., Imajo, K., Nogami, A., Taguri, M., Kirikoshi, H., Saito, S., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1993 · Cited by 43
Shen, L., Li, A., Xu, H., Shi, J., You, D., Yu, X., Xu, W., Sun, J., & Wang, F. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0354-7 · Cited by 43
Katsogiannos, P., Kamble, P. G., Pereira, M. J., Sundbom, M., Carlsson, P., Eriksson, J. W., & Espes, D. (2021) · Obesity · doi:10.1002/oby.23093 · Cited by 43
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
Kosmalski, M., Śliwińska, A., & Drzewoski, J. (2023) · Biomedicines · doi:10.3390/biomedicines11041097 · Cited by 42
Self-citationWu, D., Yan, Z.-B., Cheng, Y., Zhong, M., Liu, S.-Z., Zhang, G., & Hu, S. (2017) · Metabolism · doi:10.1016/j.metabol.2017.10.015 · Cited by 41
Starr, K. N. P., Orenduff, M. C., McDonald, S. R., Mulder, H. S., Sloane, R. J., Pieper, C. F., & Bales, C. W. (2019) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2018.1564200 · Cited by 41
Khajehdehi, P., Roozbeh, J., & Mostafavi, H. (2002) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/003655902753679454 · Cited by 40
Amerikanou, C., Papada, E., Gioxari, A., Smyrnioudis, I., Kleftaki, S.-A., Valsamidou, E., Bruns, V., Banerjee, R., Trivella, M. G., Milić, N., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105753 · Cited by 40
Tang, Y., Cao, G., Min, X., Wang, T., Sun, S., Du, X., & Zhang, W. (2018) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-018-0644-y · Cited by 39
Haidari, F., Hojhabrimanesh, A., Helli, B., Seyedian, S. S., & Angali, K. A. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.08.009 · Cited by 39
Simeone, P., Liani, R., Tripaldi, R., Castelnuovo, A. F. D., Guagnano, M. T., Tartaro, A., Bonadonna, R. C., Federico, V., Cipollone, F., Consoli, A., et al. (2018) · Nutrients · doi:10.3390/nu10121872 · Cited by 38
Liu, P., Zhang, Z., Wang, J., Zhang, X., Yu, X., & Li, Y. (2021) · Bioengineered · doi:10.1080/21655979.2021.2001240 · Cited by 38
Leite, N. C., Viegas, B. B., Villela‐Nogueira, C. A., Carlos, F. O., Cardoso, C. R. L., & Salles, G. F. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13643 · Cited by 37
Tao, G., Zhang, G., Chen, W., Yang, C., Xue, Y., Song, G., & Qin, S. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17456 · Cited by 37
Saxagliptin regulates M1/M2 macrophage polarization via CaMKKβ/AMPK pathway to attenuate NAFLD
Yang, Y., Lu, Y., Han, F., Chang, Y., Li, X., Han, Z., Xue, M., Cheng, Y., Sun, B., & Chen, L. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.090 · Cited by 35
Sakamoto, Y., Yoshio, S., Doi, H., Mori, T., Matsuda, M., Kawai, H., Shimagaki, T., Yoshikawa, S., Aoki, Y., Osawa, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.603133 · Cited by 35
Noè, A., Howard, C. P., Thuren, T. Y., Taylor, A. E., & Skerjanec, A. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.08.004 · Cited by 34
A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity
Osorio-Conles, Ó., Vega‐Beyhart, A., Ibarzábal, A., Balibrea, J. M., Graupera, I., Rimola, J., Vidal, J., & de Hollanda, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910541 · Cited by 34
Musso, G., Cassader, M., De Michieli, F., Paschetta, E., Pinach, S., Saba, F., Bongiovanni, D., Framarin, L., Berrutti, M., Leone, N., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddw400 · Cited by 33
Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis
El-Kader, S. M. A., Al-Shreef, F. M., & Al-Jiffri, O. H. (2016) · African Health Sciences · doi:10.4314/ahs.v16i1.32 · Cited by 31
Lian, X.-F., Lu, D.-H., Liu, H., Liu, Y.-J., Han, X.-Q., Yang, Y., Lin, Y., Zeng, Q., Huang, Z., Xie, F., et al. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i10.877 · Cited by 31
Wali, J. A., Gurzov, E. N., Fynch, S., Elkerbout, L., Kay, T. W. H., Masters, S. L., & Thomas, H. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113128 · Cited by 31
Alempijevic, T. M., Pantić, I., Dragašević, S., Lugonja, S., Dumic, I., & Rajilić-Stojanović, M. D. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-3308 · Cited by 29
The Acute Effects of Low-Dose TNF-αon Glucose Metabolism andβ-Cell Function in Humans
Ibfelt, T., Fischer, C. P., Plomgaard, P., van Hall, G., & Pedersen, B. K. (2014) · Mediators of Inflammation · doi:10.1155/2014/295478 · Cited by 28
Climax, J., Newsome, P. N., Hamza, M., Weissbach, M., Coughlan, D., Sattar, N., McGuire, D. K., & Bhatt, D. L. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.016334 · Cited by 26
Pervez, M. A., Khan, D. A., Mirza, S. A., et al. (2022) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2022.102866 · Cited by 26
Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice
Yang, X., Lu, F., Li, L., Li, J., Luo, J., Zhang, S., Liu, X., & Chen, G. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2443-6 · Cited by 24
Kedarisetty, C. K., Bhardwaj, A., Kumar, G., Rastogi, A., Bihari, C., Kumar, M., & Sarin, S. K. (2021) · Indian Journal of Gastroenterology · doi:10.1007/s12664-020-01131-x · Cited by 22
Matsumoto, C., Ogawa, H., Saito, Y., Okada, S., Soejima, H., Sakuma, M., Masuda, I., Nakayama, M., Doi, N., Jinnouchi, H., et al. (2019) · Diabetes Care · doi:10.2337/dc19-1188 · Cited by 21
Wang, F., Stappenbeck, F., Tang, L.-Y., Zhang, Y. E., Hui, S. T. Y., Lusis, A. J., & Parhami, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105478 · Cited by 20
Berings, M., Wehlou, C., Verrijken, A., Deschepper, E., Mertens, I. L., Kaufman, J., Gaal, L. F. V., Ouwens, D. M., & Ruige, J. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045145 · Cited by 20
Evogliptin Directly Inhibits Inflammatory and Fibrotic Signaling in Isolated Liver Cells
Seo, H.-Y., Lee, S. H., Han, E., Hwang, J. S., Han, S., Kim, M. K., & Jang, B. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911636 · Cited by 20
Adipose tissue-associated cancer risk: Is it the fat around the liver, or the fat inside the liver?
Marchesini, G., Petroni, M. L., & Cortez‐Pinto, H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.020 · Cited by 19
Barchetta, I., Cimini, F. A., Gioannis, R. D., Ciccarelli, G., Bertoccini, L., Lenzi, A., Baroni, M. G., & Cavallo, M. G. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2998 · Cited by 17
Anti-inflammatory and anti-fibrotic effects of modafinil in nonalcoholic liver disease
Choi, S., Kim, J. A., Li, H., Jo, S.-E., Lee, H., Kim, T. H., Kim, M., Kim, S.-J., & Suh, S. H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112372 · Cited by 17
Zhou, Y., Peng, H., Liu, Z., Zhang, K. K., Jendrusch, C., Drake, M., Hao, Y., & Xie, L. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0144-2 · Cited by 15
PCB118 Induces Inflammation of Islet Beta Cells via Activating ROS‐NLRP3 Inflammasome Signaling
Jiang, C., Wang, Y., Guo, M., Long, Y., Chen, J., Fan, F., Tang, S. J., & Xu, Y. (2021) · BioMed Research International · doi:10.1155/2021/5522578 · Cited by 15
Lin, M., Wu, W., Chen, Y., Lu, C., Su, S., Kuo, F.-C., Chou, Y., & Sun, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113186 · Cited by 15
Type 2 diabetes–associated polymorphisms correlate with SIRT1 and TGF‐β1 gene expression
Ramírez, Á., Hernández, M. A., Suárez‐Sánchez, R., Ortega‐Camarillo, C., Peralta‐Romero, J., Gómez-Zamudio, J. H., Valladares, A., Cruz, M., Vázquez‐Moreno, M. A., & Suárez‐Sánchez, F. (2019) · Annals of Human Genetics · doi:10.1111/ahg.12363 · Cited by 14
Mitrovic, B., Gluvic, Z. M., Μacut, D., et al. (2021) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530321666210225110140 · Cited by 14
Zhao, X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14875 · Cited by 13
Nordmann, T. M., Seelig, E., Timper, K., Cordes, M., Coslovsky, M., Hanssen, H., Schmidt‐Trucksäss, A., & Donath, M. Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139662 · Cited by 12
Dauriz, M., Trombetta, M., Boselli, L., Santi, L., Brangani, C., Pichiri, I., Bonora, E., & Bonadonna, R. C. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0807-z · Cited by 10
Huang, X.-T., Xiong, D., Xiao, J., Deng, L., Liu, W., & Tang, S. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.04.131 · Cited by 5
Cited by
Lin, S., Deng, Y., Huang, J., Li, M., Sooranna, S. R., Qin, M., & Tan, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-99622-4 · Cited by 35
Metadata
- Authors
- Frankowski, R., Kobierecki, M., Wittczak, A., Różycka-Kosmalska, M., Pietras, T., Sipowicz, K., & Kosmalski, M.
- Affiliations
- Medical University of Lodz (PL)
- The Maria Grzegorzewska University (PL)
- Corresponding author
- Kosmalski, Marcin
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-06-02
- Volume
- 24
- Issue
- 11
- Pages
- 9677
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC10254034
- OpenAlex
- W4379141887
- Cited by
- 58
- References
- 173
- Citations by year
- 2026: 12 · 2025: 33 · 2024: 12 · 2023: 1
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Medical University of Lodz (503/1-151-07/503-11-001-18)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- type 2 diabetes, non-alcoholic fatty liver disease, chronic inflammation, pathogenesis, disease progression, inflammatory signaling, DNA methylation, gene expression regulation, metabolic disorders
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Inflammation, Signal Transduction, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.